Lexeo Therapeutics (LXEO) Amortization - Intangibles (2025 - 2026)
Lexeo Therapeutics' (LXEO) quarterly Amortization - Intangibles came in at $42000.0 in Q1 2026, up 450.0% year-on-year from $7636.4 in Q1 2025, and up 119.35% quarter-over-quarter from -$217000.0 in Q4 2025.
Lexeo Therapeutics (LXEO) Amortization - Intangibles (2025 - 2026) Analysis & Trends
Lexeo Therapeutics has disclosed Amortization - Intangibles across 2 years of filings, most recently posting $42000.0 for Q1 2026.
- Amortization - Intangibles for Q1 2026 came in at $42000.0, up 450.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$81000.0 (changed N/A YoY), and the FY2025 annual result was -$111000.0, down 582.61% from the prior year.
- Amortization - Intangibles came in at $42000.0 for Q1 2026 at Lexeo Therapeutics, up from -$217000.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $60000.0 in Q3 2025 to a low of -$217000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lexeo Therapeutics | 405.92 Mn | 212.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42,000.00 |
| Dec 31, 2025 | -217,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | -12,000.00 |